anti-gpc3-irdye800cw
mAbexperimentalADCImaging agent
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 10, 2021 (NCT05047510)
Timeline
No events for the selected filters.
Mechanism of action
- Glypican-3BINDING AGENT
GPC3
Chemistry & pharmacology
- Imaging
- IRDye800CW
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05047510 | N/A | Sep 10, 2021 | Chinese Academy of Medical Sciences |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2021 |
1 organizations
Page 1 / 1